Dr Sanjat S ChiwaneDr. Sanjat Chiwane
MBBS, MD(Internal Medicine), DM(Cardiology)
Senior Consultant Cardiology, Columbia Asia Hospital
Dr. Sanjat Chiwane is MBBS, MD (Internal Medicine), DM (Cardiology) and is MCI certified specialist in Cardiology and Internal Medicine at Columbia Asia Hospital at Palam Vihar. In his stint of 9 years of experience, he has gained expertise in cardiology. His practice area includes Adult Cardiac Interventions, Functional Angioplasty, Cardiac Pacemaker Implantations, Cardiac Resynchronisation therapy and AICD Implantations, Paediatric Cardiac Catheterization & Device closure and Ecocardiography. He has been awarded Honors in Anatomy, Biochemistry, Physiology, Pathology, Pharmacology & General Surgery. He has also been commended by Nigeria Delta Corporation for humanitarian service to the people of Ondo State, Nigeria. He has conducted various researches viz. delivery study, Optimind Study, Signify Study and TAO study. He has also deliberated a number of case presentations at scientific conferences across the globe. He is affiliated and/or is a member of Association of Physicians of India and Cardiological Society of India. Further, he has the honor of being a faculty member at TCT-Asia Pacific, ACVS India and IIC India.
• “Antithrombotic therapy in acute coronary syndromes: What Recent trials have to say”. Published in CSI Cardiology Update 2009.• “Percutaneous Intervention in post-MI patients”, CARDICON 2010, Patna.• “Hypotension and Shock”. API Textbook of Medicine Vol 7. Dr. Anil Dhall and Dr. Sanjat. S.Chiwane
RESEARCH
• DELIVER STUDY (Deliverability of the Resolute Integrity in All-Comer Vessels and Cross Over stenting)• OPTIMIND Study: Clinical Outcomes of Patients according to pacing Modality and primary
Indications.• SIGNIFY Study: Effects of Ivabradine in patients with stable coronary artery disease without clinical heart failure. A randomised double blind placebo controlled international multicenter study.• TAO Study: A randomized double blind, triple dummy trial to compare efficacy of Otamixaban with Unfractionated Heparin with Eptifibatide, in patients with Unstable angina/Non ST segment elevation Myocardial Infarction scheduled to undergo early invasive strategy.
false
Stay updated with our latest products and services